Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WIN378 in Moderate to Severe COPD
NCT07646587Phase 2Recruiting
- Sponsor
- Windward Bio
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 2
01
Overview
A Phase 2 trial of WIN378 in chronic obstructive pulmonary disease (COPD), sponsored by Windward Bio. Started Jun 2026; status: recruiting.
02
Drugs
WIN378
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07646587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07646587.